BioCentury
ARTICLE | Company News

Aradigm, Genentech deal

February 12, 2001 8:00 AM UTC

DNA discontinued development of rhDNase recombinant deoxyribonuclease using ARDM's AERx Pulmonary Drug Delivery System inhaler to treat cystic fibrosis. RhDNase is the active ingredient of DNA's marke...